Medication info

Rosustine Tablets 5 mg (Rosuvastatin Calcium)

Prescription medicationTabletExpired
Ingredient · strength
Rosuvastatin Calcium›5.2mg / 1 tablet
Manufacturer / importer
Highple Life Science Co., Ltd.
Appearance
Yellow round film-coated tablet
Packaging
30 tablets (15 tablets/PTP × 2 packs)
Approval status
Expired

MFDS item code 201901166 · Approved 2019.02.25

This product's status changed to Expired on 2024.02.25. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Before and during treatment with this medicine, patients should follow a standard cholesterol-lowering diet and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased up to a maximum of 20 milligrams daily. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary for patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medicine at a dose of 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Since systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
Children's dosage
2. Pediatric patients with heterozygous familial hypercholesterolemia (aged 10 to 17 years) The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) The dose should be individually adjusted according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. The safety and efficacy in children under 10 years of age have not been established.

Ingredients

Manufacturer
Highple Life Science Co., Ltd.

Efficacy & effects

Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease

  • Primary hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • familial hypercholesterolemia
  • dysbetalipoproteinemia
  • coronary heart disease
  • stroke
  • myocardial infarction
View approved original text

This medication is primarily used as an adjunct in patients with hypercholesterolemia and hyperlipidemia when dietary measures or exercise alone are inadequate. It lowers cholesterol levels in patients with primary hypercholesterolemia and mixed hyperlipidemia, delays the progression of atherosclerosis, and is effective as an adjunct to diet in patients with homozygous familial hypercholesterolemia and dysbetalipoproteinemia. Additionally, it aids in reducing total cholesterol and LDL cholesterol in pediatric patients aged 10 to 17 with familial hypercholesterolemia. This drug is also used in adults at high risk of cardiovascular diseases to reduce the risk of stroke, myocardial infarction, and arterial revascularization. In summary, this medication is effective for cholesterol management and reducing the risk of cardiovascular diseases.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Before and during treatment with this medicine, patients should follow a standard cholesterol-lowering diet and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased up to a maximum of 20 milligrams daily. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary for patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medicine at a dose of 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Since systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.

Children's dosage

2. Pediatric patients with heterozygous familial hypercholesterolemia (aged 10 to 17 years) The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) The dose should be individually adjusted according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. The safety and efficacy in children under 10 years of age have not been established.

Precautions

This medication should not be given to certain patients. First, persons who have had allergic reactions to this medication must not use it. Patients with active liver disease or significantly elevated liver enzyme levels should not take this drug. Patients with muscle disorders or severely impaired kidney function should also refrain from using this medication. Women who are pregnant, nursing, or capable of becoming pregnant must use appropriate contraceptive methods and only take it if they understand the potential risks to the fetus. Additionally, patients at high risk for muscle disorders should avoid high doses. This medication contains lactose, so patients with lactose intolerance should not take it. Caution is needed when consuming alcohol or if there is a history of liver disease. Regular liver function tests must be conducted, and existing conditions such as hypothyroidism or nephrotic syndrome must be treated first. If symptoms such as muscle pain or weakness occur, medical assistance should be sought immediately, and blood tests should be conducted to assess muscle damage. Extra caution is recommended for patients with renal impairment, elderly patients, or those with a history of alcohol abuse. This medication can rarely cause serious side effects such as liver damage, myositis, or rhabdomyolysis; if any symptoms appear, the medication should be stopped immediately, and a doctor consulted. Furthermore, if a serious rash or allergic reaction occurs, usage must be stopped immediately. This medication may interact with other drugs, so if you are currently taking any medication, you must inform your doctor or pharmacist. In particular, muscle damage risk may increase when taken with certain antiviral agents, immunosuppressants, antifungals, some antibiotics, and fibric acid derivatives. Safety has not been established for use during pregnancy or breastfeeding, so it should not be taken under these conditions and women capable of becoming pregnant must use proper contraception. In cases of overdose, there is no specific antidote, and treatment should be based on symptoms with liver function and muscle enzyme tests performed. This medication is unlikely to affect driving or operating machinery, but caution should be taken as dizziness may occur.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, multiple neuropathies, amnesia, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia with systemic symptoms drug reaction syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, paresthesia, chest discomfort, decreased appetite, abdominal distension, syncope, widespread pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, and it is safest to keep it at room temperature between 1°C and 30°C. Therefore, to maintain the medication's effectiveness, it is advisable to store it in a cool, dry place away from direct sunlight.

Appearance and packaging

Appearance

Yellow round film-coated tablet

Package unit

30 tablets (15 tablets/PTP × 2 packs)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.